AVLVX | VIVIX | AVLVX / VIVIX | |
Total Expense Ratio | 0.15 | 0.04 | 375% |
Annual Report Gross Expense Ratio | 0.15 | 0.04 | 375% |
Fund Existence | 3 years | 27 years | - |
Gain YTD | 7.470 | 7.866 | 95% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 5000000 | 5000000 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 368M | 203B | 0% |
Annual Yield % from dividends | 1.50 | 2.11 | 71% |
Returns for 1 year | 14.01 | 7.74 | 181% |
Returns for 3 years | 53.34 | 36.61 | 146% |
Returns for 5 years | N/A | 70.16 | - |
Returns for 10 years | N/A | 131.61 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JAGLX | 70.01 | 0.54 | +0.78% |
Janus Henderson Global Life Sciences T | |||
PSOPX | 29.15 | 0.09 | +0.31% |
JPMorgan Small Cap Value I | |||
RIBEX | 65.39 | N/A | N/A |
American Funds Invmt Co of Amer R2E | |||
ZGFIX | 19.70 | -0.03 | -0.15% |
American Beacon Ninety One Gbl Frnchs R5 | |||
TMLPX | 8.76 | -0.05 | -0.57% |
Transamerica Energy Infrastructure I |